For patients with allergic rhinitis, twice-daily azelastine plus fluticasone cut nasal symptoms ... Add-on oral antihistamines or montelukast (Singulair) do not add much benefit.

Many people turn to oral antihistamines or montelukast for relief ... If symptoms remain uncontrolled with one spray, combining nasal steroids with nasal antihistamines provides better relief ...

His medication list included albuterol, budesonide-formoterol inhaler, fluticasone nasal spray, montelukast, tiotropium bromide inhaler, and loratadine daily." ...

The U.S. Food and Drug Administration is recalling 89,312 bottles of NasoGel nasal spray because the product might cause ...

Retired electrician Joe Walsh in December became the first Alzheimer’s patient to try a nasal spray used to treat other ...

The FDA has accepted for review the NDA for bumetanide nasal spray for edema associated with CHF, as well as hepatic and renal disease.

The drug is designed to reduce inflammation in the brain and has been used on MS, cancer and migraine headaches.

The trial will evaluate the safety and effectiveness of a next-generation vaccine administered through a nasal spray or ...

The nasal spray Spravato, which is made from the drug esketamine, had been approved in 2019 for patients who failed to respond to at least two oral antidepressants. However, it had to be used in ...

Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Montelukast (Singulair) held no elevated risk of depression, anxiety, suicidality, or behavioral problems for children ...

Joe Walsh is now testing a new treatment using a nasal spray, the medication inside is called Foralumab. He is the first patient with Alzheimer's to try it. The Walsh family is hopeful. Foralumab is ...

Nial Wheate in the past has received funding from the ACT Cancer Council, Tenovus Scotland, Medical Research Scotland, Scottish Crucible, and the Scottish Universities Life Sciences Alliance.